0001127602-23-014739.txt : 20230505 0001127602-23-014739.hdr.sgml : 20230505 20230505165407 ACCESSION NUMBER: 0001127602-23-014739 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230503 FILED AS OF DATE: 20230505 DATE AS OF CHANGE: 20230505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Karachun Rita A CENTRAL INDEX KEY: 0001601572 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 23894712 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0407 4 2023-05-03 0000310158 Merck & Co., Inc. MRK 0001601572 Karachun Rita A MERCK & CO., INC. 126 EAST LINCOLN AVENUE RAHWAY NJ 07065 1 Sr. VP Fince-Global Controller 0 Common Stock 2023-05-03 4 M 0 803 117.89 A 45362.972 D Common Stock 2023-05-03 4 F 0 276 117.89 D 45086.972 D Common Stock 2023-05-04 4 M 0 949 118.22 A 46035.972 D Common Stock 2023-05-04 4 F 0 326 118.22 D 45709.972 D Common Stock 2023-05-04 4 M 0 15875 62.07 A 61584.972 D Common Stock 2023-05-04 4 S 0 15875 117.5334 D 45709.972 D Restricted Stock Unit 2023-05-03 4 M 0 803 0 D 2023-05-03 2025-05-03 Common Stock 803 1608 D Restricted Stock Unit 2023-05-04 4 M 0 949 0 D 2022-05-04 2024-05-04 Common Stock 949 951 D Stock Option (Right to Buy) 62.07 2023-05-04 4 M 0 15875 0 D 2018-05-05 2027-05-04 Common Stock 15875 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.5000 to $117.6200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2023, 5/3/2024 and 5/3/2025. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024. The option became exercisable in equal installments on 5/5/2018, 5/5/2019 and 5/5/2020. /s/ Kelly E. W. Grez as Attorney-in-Fact for Rita Karachun 2023-05-05